Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.305
-0.005 (-0.15%)
Mar 31, 2025, 1:18 PM EDT - Market open
Evotec SE Employees
Evotec SE had 5,061 employees as of December 31, 2023. The number of employees increased by 109 or 2.20% compared to the previous year.
Employees
5,061
Change (1Y)
109
Growth (1Y)
2.20%
Revenue / Employee
$171,244
Profits / Employee
-$37,766
Market Cap
1.15B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EVO News
- 27 days ago - Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb - Accesswire
- 4 weeks ago - Evotec Announces Change in Management Board - Accesswire
- 5 weeks ago - Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior Partner - Business Wire
- 2 months ago - Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases - Accesswire
- 3 months ago - Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha
- 3 months ago - Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk - Accesswire
- 4 months ago - Comment on Withdrawn Non-Binding Offer - Accesswire
- 4 months ago - Halozyme withdraws $2.1 bln buyout offer for Evotec - Reuters